Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
Background: Vitamin K antagonists have been the treatment of choice in preventing thromboembolic events, but problems such as frequent dose adjustment and monitoring of coagulation status, including multiple drug and food interactions, make their use difficult. Dabigatran etexilate is a new oral dir...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Centro de Investigaciones y Publicaciones Farmaceuticas,
2013-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|